Related Experiment Video
Updated: May 25, 2026

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
Published on: May 4, 2012
[Keratin fragments as a serological indicator in patients with a liver disease]
J Lata1, H Mrlianová, O Stibůrek
1Interní klinika Lékarské fakulty Ostravské univerzity a FN Ostrava. Jan.Lata@osu.cz
Introduction:
Determination of M30 antigen appears to be a sensitive method for evaluation of hepatocyte apoptosis. The aim of the present project was to implement this technique, compare M30 values in patients with a liver disease and healthy controls and to identify potential relationships between M30 values and other parameters.
Methods:
M30 antigen was assessed in 25 patients with a liver disease and 30 healthy controls. These results were compared between patients with a liver disease and the controls and correlated to a range of clinical and laboratory values, including tissue polypeptide-specific antigen (TPS), in patients with a liver disease.
Results:
We found significant differences in M30 values between controls and patients with a liver disease. The only significant correlations were the correlation between M30 and ALT, highly significant correlation between M30 and AST and highly significant correlation between M30 and TPS.
Conclusion:
The M30 antigen is a sensitive indicator of liver damage. Considering the highly significant correlation with TPS, it can be assumed that in some liver diseases, TPS could serve as a clinically useful indicator of apoptosis.
Insights
M30 antigen is a sensitive indicator of liver damage, showing significant differences between patients and healthy controls. It strongly correlates with liver enzymes (ALT, AST) and tissue polypeptide-specific antigen (TPS), suggesting TPS may also indicate liver apoptosis.
Area of Science:
- Hepatology
- Biochemistry
- Clinical Diagnostics
Context:
- Hepatocyte apoptosis evaluation is crucial for understanding liver disease progression.
- M30 antigen is recognized as a sensitive marker for assessing liver cell apoptosis.
Purpose:
- To implement M30 antigen assessment for hepatocyte apoptosis.
- To compare M30 levels in liver disease patients versus healthy controls.
- To explore correlations between M30 values and clinical/laboratory parameters.
Summary:
- M30 antigen levels were significantly different between liver disease patients (n=25) and healthy controls (n=30).
- Significant correlations were observed between M30 and ALT, AST, and tissue polypeptide-specific antigen (TPS).
- M30 serves as a sensitive indicator of liver damage, with TPS potentially indicating apoptosis in certain liver conditions.
Impact:
- Establishes M30 antigen as a valuable tool for quantifying hepatocyte apoptosis in clinical settings.
- Highlights the potential of TPS as a surrogate marker for apoptosis in liver disease.
- Provides insights into the relationship between apoptosis markers and liver injury severity.
Related Concept Videos
Cirrhosis I: Introduction
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...

